Literature DB >> 24413533

Future opportunities in cancer nanotechnology--NCI strategic workshop report.

Piotr Grodzinski1, Dorothy Farrell.   

Abstract

There has been significant progress in utilizing nanotechnology in several areas of cancer care, including in vitro diagnostics, imaging, and therapy. The National Cancer Institute, which currently supports an array of research activities in cancer nanotechnology, convened a strategic workshop to explore the most promising directions and areas for future resource investment. The major discussion points as well as the opportunities identified are presented herein. ©2014 AACR

Entities:  

Mesh：

Year:  2014        PMID： 24413533      PMCID： PMC6624848          DOI： 10.1158/0008-5472.CAN-13-2787

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

2.  Single-cell proteomic chip for profiling intracellular signaling pathways in single tumor cells.

Authors:  Qihui Shi; Lidong Qin; Wei Wei; Feng Geng; Rong Fan; Young Shik Shin; Deliang Guo; Leroy Hood; Paul S Mischel; James R Heath
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

Review 3.  Nanomedicine(s) under the microscope.

Authors:  Ruth Duncan; Rogerio Gaspar
Journal:  Mol Pharm       Date:  2011-10-26       Impact factor: 4.939

Review 4.  Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy.

Authors:  Erin R Steenblock; Stephen H Wrzesinski; Richard A Flavell; Tarek M Fahmy
Journal:  Expert Opin Biol Ther       Date:  2009-04       Impact factor: 4.388

5.  Micro-NMR for rapid molecular analysis of human tumor samples.

Authors:  Jered B Haun; Cesar M Castro; Rui Wang; Vanessa M Peterson; Brett S Marinelli; Hakho Lee; Ralph Weissleder
Journal:  Sci Transl Med       Date:  2011-02-23       Impact factor: 17.956

6.  Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

Authors:  Jeffrey Hrkach; Daniel Von Hoff; Mir Mukkaram Ali; Elizaveta Andrianova; Jason Auer; Tarikh Campbell; David De Witt; Michael Figa; Maria Figueiredo; Allen Horhota; Susan Low; Kevin McDonnell; Erick Peeke; Beadle Retnarajan; Abhimanyu Sabnis; Edward Schnipper; Jeffrey J Song; Young Ho Song; Jason Summa; Douglas Tompsett; Greg Troiano; Tina Van Geen Hoven; Jim Wright; Patricia LoRusso; Philip W Kantoff; Neil H Bander; Christopher Sweeney; Omid C Farokhzad; Robert Langer; Stephen Zale
Journal:  Sci Transl Med       Date:  2012-04-04       Impact factor: 17.956

Review 7.  Cancer nanomedicines: so many papers and so few drugs!

Authors:  Vincent J Venditto; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2012-10-01       Impact factor: 15.470

8.  Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.

Authors:  Uma Prabhakar; Hiroshi Maeda; Rakesh K Jain; Eva M Sevick-Muraca; William Zamboni; Omid C Farokhzad; Simon T Barry; Alberto Gabizon; Piotr Grodzinski; David C Blakey
Journal:  Cancer Res       Date:  2013-02-19       Impact factor: 12.701

9.  Nanoparticles that communicate in vivo to amplify tumour targeting.

Authors:  Geoffrey von Maltzahn; Ji-Ho Park; Kevin Y Lin; Neetu Singh; Christian Schwöppe; Rolf Mesters; Wolfgang E Berdel; Erkki Ruoslahti; Michael J Sailor; Sangeeta N Bhatia
Journal:  Nat Mater       Date:  2011-06-19       Impact factor: 43.841

10.  Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling.

Authors:  Gaurav Sahay; William Querbes; Christopher Alabi; Ahmed Eltoukhy; Sovan Sarkar; Christopher Zurenko; Emmanouil Karagiannis; Kevin Love; Delai Chen; Roberto Zoncu; Yosef Buganim; Avi Schroeder; Robert Langer; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2013-06-23       Impact factor: 54.908
  10 in total
  13 in total

1.  P-selectin is a nanotherapeutic delivery target in the tumor microenvironment.

Authors:  Yosi Shamay; Moshe Elkabets; Hongyan Li; Janki Shah; Samuel Brook; Feng Wang; Keren Adler; Emily Baut; Maurizio Scaltriti; Prakrit V Jena; Eric E Gardner; John T Poirier; Charles M Rudin; José Baselga; Adriana Haimovitz-Friedman; Daniel A Heller
Journal:  Sci Transl Med       Date:  2016-06-29       Impact factor: 17.956

2.  Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.

Authors:  Swetha Inturi; Guankui Wang; Fangfang Chen; Nirmal K Banda; V Michael Holers; LinPing Wu; Seyed Moein Moghimi; Dmitri Simberg
Journal:  ACS Nano       Date:  2015-10-21       Impact factor: 15.881

3.  Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer.

Authors:  Wenwu Xiao; Nell Suby; Kai Xiao; Tzu-Yin Lin; Nasir Al Awwad; Kit S Lam; Yuanpei Li
Journal:  J Control Release       Date:  2017-08-25       Impact factor: 9.776

Review 4.  Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.

Authors:  Christopher M Hartshorn; Michelle S Bradbury; Gregory M Lanza; Andre E Nel; Jianghong Rao; Andrew Z Wang; Ulrich B Wiesner; Lily Yang; Piotr Grodzinski
Journal:  ACS Nano       Date:  2017-12-22       Impact factor: 15.881

Review 5.  One-component nanomedicine.

Authors:  Hao Su; Jin Mo Koo; Honggang Cui
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

6.  Pharmacokinetic analysis reveals limitations and opportunities for nanomedicine targeting of endothelial and extravascular compartments of tumours.

Authors:  Michael J Benchimol; David Bourne; Seyed Moein Moghimi; Dmitri Simberg
Journal:  J Drug Target       Date:  2019-02-04       Impact factor: 5.121

Review 7.  National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics.

Authors:  Christopher M Hartshorn; Luisa M Russell; Piotr Grodzinski
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-07-01

8.  Recent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid Tumors.

Authors:  Yi Wen; Wilson S Meng
Journal:  J Pharm Innov       Date:  2014-06-01       Impact factor: 2.750

9.  Quantitative contributions of processes by which polyanion drugs reduce intracellular bioavailability and transfection efficiency of cationic siRNA lipoplex.

Authors:  Pharavee Jaiprasart; Bertrand Z Yeung; Ze Lu; M Guillaume Wientjes; Minjian Cui; Chien-Ming Hsieh; Sukyung Woo; Jessie L-S Au
Journal:  J Control Release       Date:  2017-12-22       Impact factor: 9.776

10.  Carboxymethyl Hyaluronan-Stabilized Nanoparticles for Anticancer Drug Delivery.

Authors:  Jessica L Woodman; Min Sung Suh; Jianxing Zhang; Yuvabharath Kondaveeti; Diane J Burgess; Bruce A White; Glenn D Prestwich; Liisa T Kuhn
Journal:  Int J Cell Biol       Date:  2015-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.